Change in ADS ratio

RNS Number : 3556R

AstraZeneca PLC

26 June 2015

 



AstraZeneca PLC - Change in ADS ratio

AstraZeneca PLC (the "Company") today announces an intended ratio change to its NYSE-listed sponsored Level 2 American Depositary Receipt ("ADR") programme. The current ratio is one (1) American Depositary Share ("ADS") per one (1) Ordinary Share. The new ratio will be two (2) ADSs per one (1) Ordinary Share. The expected effective date for the ratio change is 27 July 2015. There will be no change to the underlying Ordinary Shares.

ADS holders at the close of business New York time on the record date, 22 July 2015, will receive a distribution of one additional ADS for every ADS held. The new ADSs are expected to be distributed on 24 July 2015. No action is required by ADS holders to effect this change.

Contact details for Citibank, N.A., the Company's ADR depositary, can be found below.

A C N Kemp

Company Secretary

26 June 2015

CONTACT

Citibank Shareholder Services

PO Box 43077  Providence RI 02940-3077 US

Tel (toll free in the US): [phone] Tel (outside the US): [phone]

Media Enquiries

Esra Erkal-Paler	[phone] (UK/Global)
Jacob Lund	[phone] (Sweden)
Michele Meixell	+ 1 302 885 6351 (US)

Investor Enquiries

UK
Thomas Kudsk Larsen		[phone]	mob: [phone]
Eugenia Litz	Respiratory, Inflammation and Autoimmunity	[phone]	mob: [phone]
Nick Stone	Cardiovascular and Metabolic Disease	[phone]	mob: [phone]
Karl Hård	Oncology	[phone]	mob: [phone]
Craig Marks	Infection, Neuroscience and Gastrointestinal Disease	[phone]	mob: [phone]
Christer Gruvris		[phone]	mob: [phone]
US
Dial / Toll-Free		301-398-3251	866-381-7277

 

END

 

 

MSCLLFFIRIIRFIE